AstraZeneca’s antibody therapy prevents COVID-19

AstraZeneca said on Friday that its antibody therapy met the main goal of preventing COVID-19 disease in a late-stage study, putting the British drugmaker on track to potentially offer an alternative to vaccines for people with weakened immune systems.